AI Medical Imaging Software for Lung Diseases Industry Research Report 2025
Summary
According to APO Research, The global AI Medical Imaging Software for Lung Diseases market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for AI Medical Imaging Software for Lung Diseases is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for AI Medical Imaging Software for Lung Diseases is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for AI Medical Imaging Software for Lung Diseases is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of AI Medical Imaging Software for Lung Diseases include Riverain Technologies, BioMind, Fosun Aitrox, Huiying Medical, United-Imaging, Deepwise, Shukun Technology, VoxelCloud and Infervision Medical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for AI Medical Imaging Software for Lung Diseases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI Medical Imaging Software for Lung Diseases.
The AI Medical Imaging Software for Lung Diseases market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global AI Medical Imaging Software for Lung Diseases market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
AI Medical Imaging Software for Lung Diseases Segment by Company
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Medical Imaging Software for Lung Diseases market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI Medical Imaging Software for Lung Diseases and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Medical Imaging Software for Lung Diseases.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of AI Medical Imaging Software for Lung Diseases companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
According to APO Research, The global AI Medical Imaging Software for Lung Diseases market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for AI Medical Imaging Software for Lung Diseases is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for AI Medical Imaging Software for Lung Diseases is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for AI Medical Imaging Software for Lung Diseases is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of AI Medical Imaging Software for Lung Diseases include Riverain Technologies, BioMind, Fosun Aitrox, Huiying Medical, United-Imaging, Deepwise, Shukun Technology, VoxelCloud and Infervision Medical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for AI Medical Imaging Software for Lung Diseases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI Medical Imaging Software for Lung Diseases.
The AI Medical Imaging Software for Lung Diseases market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global AI Medical Imaging Software for Lung Diseases market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
AI Medical Imaging Software for Lung Diseases Segment by Company
- Riverain Technologies
- BioMind
- Fosun Aitrox
- Huiying Medical
- United-Imaging
- Deepwise
- Shukun Technology
- VoxelCloud
- Infervision Medical
- Siemens
- Yizhun Intelligent
- Pulmonary Nodules
- Pneumonia
- Other
- Hospital
- Clinic
- Hospital
- Clinic
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Russia
- Netherlands
- Nordic Countries
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- Taiwan
- Southeast Asia
- South America
- Brazil
- Argentina
- Chile
- Middle East & Africa
- Saudi Arabia
- Israel
- United Arab Emirates
- Turkey
- Iran
- Egypt
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Medical Imaging Software for Lung Diseases market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI Medical Imaging Software for Lung Diseases and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Medical Imaging Software for Lung Diseases.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of AI Medical Imaging Software for Lung Diseases companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 AI Medical Imaging Software for Lung Diseases by Type
2.2.1 Market Value Comparison by Type (2020 VS 2024 VS 2031)
2.2.2 Pulmonary Nodules
2.2.3 Pneumonia
2.2.4 Other
2.3 AI Medical Imaging Software for Lung Diseases by Application
2.3.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.3.2 Hospital
2.3.3 Clinic
2.4 Assumptions and Limitations
3 AI MEDICAL IMAGING SOFTWARE FOR LUNG DISEASES BREAKDOWN DATA BY TYPE
3.1 Global AI Medical Imaging Software for Lung Diseases Historic Market Size by Type (2020-2025)
3.2 Global AI Medical Imaging Software for Lung Diseases Forecasted Market Size by Type (2026-2031)
4 AI MEDICAL IMAGING SOFTWARE FOR LUNG DISEASES BREAKDOWN DATA BY APPLICATION
4.1 Global AI Medical Imaging Software for Lung Diseases Historic Market Size by Application (2020-2025)
4.2 Global AI Medical Imaging Software for Lung Diseases Forecasted Market Size by Application (2026-2031)
5 GLOBAL GROWTH TRENDS
5.1 Global AI Medical Imaging Software for Lung Diseases Market Perspective (2020-2031)
5.2 Global AI Medical Imaging Software for Lung Diseases Growth Trends by Region
5.2.1 Global AI Medical Imaging Software for Lung Diseases Market Size by Region: 2020 VS 2024 VS 2031
5.2.2 AI Medical Imaging Software for Lung Diseases Historic Market Size by Region (2020-2025)
5.2.3 AI Medical Imaging Software for Lung Diseases Forecasted Market Size by Region (2026-2031)
5.3 AI Medical Imaging Software for Lung Diseases Market Dynamics
5.3.1 AI Medical Imaging Software for Lung Diseases Industry Trends
5.3.2 AI Medical Imaging Software for Lung Diseases Market Drivers
5.3.3 AI Medical Imaging Software for Lung Diseases Market Challenges
5.3.4 AI Medical Imaging Software for Lung Diseases Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top AI Medical Imaging Software for Lung Diseases Players by Revenue
6.1.1 Global Top AI Medical Imaging Software for Lung Diseases Players by Revenue (2020-2025)
6.1.2 Global AI Medical Imaging Software for Lung Diseases Revenue Market Share by Players (2020-2025)
6.2 Global AI Medical Imaging Software for Lung Diseases Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of AI Medical Imaging Software for Lung Diseases Head Office and Area Served
6.4 Global AI Medical Imaging Software for Lung Diseases Players, Product Type & Application
6.5 Global AI Medical Imaging Software for Lung Diseases Manufacturers Established Date
6.6 Global AI Medical Imaging Software for Lung Diseases Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America AI Medical Imaging Software for Lung Diseases Market Size (2020-2031)
7.2 North America AI Medical Imaging Software for Lung Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 North America AI Medical Imaging Software for Lung Diseases Market Size by Country (2020-2025)
7.4 North America AI Medical Imaging Software for Lung Diseases Market Size by Country (2026-2031)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 EUROPE
8.1 Europe AI Medical Imaging Software for Lung Diseases Market Size (2020-2031)
8.2 Europe AI Medical Imaging Software for Lung Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
8.3 Europe AI Medical Imaging Software for Lung Diseases Market Size by Country (2020-2025)
8.4 Europe AI Medical Imaging Software for Lung Diseases Market Size by Country (2026-2031)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size (2020-2031)
9.2 Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size by Country (2020-2025)
9.4 Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size by Country (2026-2031)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 SOUTH AMERICA
10.1 South America AI Medical Imaging Software for Lung Diseases Market Size (2020-2031)
10.2 South America AI Medical Imaging Software for Lung Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 South America AI Medical Imaging Software for Lung Diseases Market Size by Country (2020-2025)
10.4 South America AI Medical Imaging Software for Lung Diseases Market Size by Country (2026-2031)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa AI Medical Imaging Software for Lung Diseases Market Size (2020-2031)
11.2 Middle East & Africa AI Medical Imaging Software for Lung Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
11.3 Middle East & Africa AI Medical Imaging Software for Lung Diseases Market Size by Country (2020-2025)
11.4 Middle East & Africa AI Medical Imaging Software for Lung Diseases Market Size by Country (2026-2031)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 PLAYERS PROFILED
12.1 Riverain Technologies
12.1.1 Riverain Technologies Company Information
12.1.2 Riverain Technologies Business Overview
12.1.3 Riverain Technologies Revenue in AI Medical Imaging Software for Lung Diseases Business (2020-2025)
12.1.4 Riverain Technologies AI Medical Imaging Software for Lung Diseases Product Portfolio
12.1.5 Riverain Technologies Recent Developments
12.2 BioMind
12.2.1 BioMind Company Information
12.2.2 BioMind Business Overview
12.2.3 BioMind Revenue in AI Medical Imaging Software for Lung Diseases Business (2020-2025)
12.2.4 BioMind AI Medical Imaging Software for Lung Diseases Product Portfolio
12.2.5 BioMind Recent Developments
12.3 Fosun Aitrox
12.3.1 Fosun Aitrox Company Information
12.3.2 Fosun Aitrox Business Overview
12.3.3 Fosun Aitrox Revenue in AI Medical Imaging Software for Lung Diseases Business (2020-2025)
12.3.4 Fosun Aitrox AI Medical Imaging Software for Lung Diseases Product Portfolio
12.3.5 Fosun Aitrox Recent Developments
12.4 Huiying Medical
12.4.1 Huiying Medical Company Information
12.4.2 Huiying Medical Business Overview
12.4.3 Huiying Medical Revenue in AI Medical Imaging Software for Lung Diseases Business (2020-2025)
12.4.4 Huiying Medical AI Medical Imaging Software for Lung Diseases Product Portfolio
12.4.5 Huiying Medical Recent Developments
12.5 United-Imaging
12.5.1 United-Imaging Company Information
12.5.2 United-Imaging Business Overview
12.5.3 United-Imaging Revenue in AI Medical Imaging Software for Lung Diseases Business (2020-2025)
12.5.4 United-Imaging AI Medical Imaging Software for Lung Diseases Product Portfolio
12.5.5 United-Imaging Recent Developments
12.6 Deepwise
12.6.1 Deepwise Company Information
12.6.2 Deepwise Business Overview
12.6.3 Deepwise Revenue in AI Medical Imaging Software for Lung Diseases Business (2020-2025)
12.6.4 Deepwise AI Medical Imaging Software for Lung Diseases Product Portfolio
12.6.5 Deepwise Recent Developments
12.7 Shukun Technology
12.7.1 Shukun Technology Company Information
12.7.2 Shukun Technology Business Overview
12.7.3 Shukun Technology Revenue in AI Medical Imaging Software for Lung Diseases Business (2020-2025)
12.7.4 Shukun Technology AI Medical Imaging Software for Lung Diseases Product Portfolio
12.7.5 Shukun Technology Recent Developments
12.8 VoxelCloud
12.8.1 VoxelCloud Company Information
12.8.2 VoxelCloud Business Overview
12.8.3 VoxelCloud Revenue in AI Medical Imaging Software for Lung Diseases Business (2020-2025)
12.8.4 VoxelCloud AI Medical Imaging Software for Lung Diseases Product Portfolio
12.8.5 VoxelCloud Recent Developments
12.9 Infervision Medical
12.9.1 Infervision Medical Company Information
12.9.2 Infervision Medical Business Overview
12.9.3 Infervision Medical Revenue in AI Medical Imaging Software for Lung Diseases Business (2020-2025)
12.9.4 Infervision Medical AI Medical Imaging Software for Lung Diseases Product Portfolio
12.9.5 Infervision Medical Recent Developments
12.10 Siemens
12.10.1 Siemens Company Information
12.10.2 Siemens Business Overview
12.10.3 Siemens Revenue in AI Medical Imaging Software for Lung Diseases Business (2020-2025)
12.10.4 Siemens AI Medical Imaging Software for Lung Diseases Product Portfolio
12.10.5 Siemens Recent Developments
12.11 Yizhun Intelligent
12.11.1 Yizhun Intelligent Company Information
12.11.2 Yizhun Intelligent Business Overview
12.11.3 Yizhun Intelligent Revenue in AI Medical Imaging Software for Lung Diseases Business (2020-2025)
12.11.4 Yizhun Intelligent AI Medical Imaging Software for Lung Diseases Product Portfolio
12.11.5 Yizhun Intelligent Recent Developments
13 REPORT CONCLUSION
14 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 AI Medical Imaging Software for Lung Diseases by Type
2.2.1 Market Value Comparison by Type (2020 VS 2024 VS 2031)
2.2.2 Pulmonary Nodules
2.2.3 Pneumonia
2.2.4 Other
2.3 AI Medical Imaging Software for Lung Diseases by Application
2.3.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.3.2 Hospital
2.3.3 Clinic
2.4 Assumptions and Limitations
3 AI MEDICAL IMAGING SOFTWARE FOR LUNG DISEASES BREAKDOWN DATA BY TYPE
3.1 Global AI Medical Imaging Software for Lung Diseases Historic Market Size by Type (2020-2025)
3.2 Global AI Medical Imaging Software for Lung Diseases Forecasted Market Size by Type (2026-2031)
4 AI MEDICAL IMAGING SOFTWARE FOR LUNG DISEASES BREAKDOWN DATA BY APPLICATION
4.1 Global AI Medical Imaging Software for Lung Diseases Historic Market Size by Application (2020-2025)
4.2 Global AI Medical Imaging Software for Lung Diseases Forecasted Market Size by Application (2026-2031)
5 GLOBAL GROWTH TRENDS
5.1 Global AI Medical Imaging Software for Lung Diseases Market Perspective (2020-2031)
5.2 Global AI Medical Imaging Software for Lung Diseases Growth Trends by Region
5.2.1 Global AI Medical Imaging Software for Lung Diseases Market Size by Region: 2020 VS 2024 VS 2031
5.2.2 AI Medical Imaging Software for Lung Diseases Historic Market Size by Region (2020-2025)
5.2.3 AI Medical Imaging Software for Lung Diseases Forecasted Market Size by Region (2026-2031)
5.3 AI Medical Imaging Software for Lung Diseases Market Dynamics
5.3.1 AI Medical Imaging Software for Lung Diseases Industry Trends
5.3.2 AI Medical Imaging Software for Lung Diseases Market Drivers
5.3.3 AI Medical Imaging Software for Lung Diseases Market Challenges
5.3.4 AI Medical Imaging Software for Lung Diseases Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top AI Medical Imaging Software for Lung Diseases Players by Revenue
6.1.1 Global Top AI Medical Imaging Software for Lung Diseases Players by Revenue (2020-2025)
6.1.2 Global AI Medical Imaging Software for Lung Diseases Revenue Market Share by Players (2020-2025)
6.2 Global AI Medical Imaging Software for Lung Diseases Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of AI Medical Imaging Software for Lung Diseases Head Office and Area Served
6.4 Global AI Medical Imaging Software for Lung Diseases Players, Product Type & Application
6.5 Global AI Medical Imaging Software for Lung Diseases Manufacturers Established Date
6.6 Global AI Medical Imaging Software for Lung Diseases Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America AI Medical Imaging Software for Lung Diseases Market Size (2020-2031)
7.2 North America AI Medical Imaging Software for Lung Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 North America AI Medical Imaging Software for Lung Diseases Market Size by Country (2020-2025)
7.4 North America AI Medical Imaging Software for Lung Diseases Market Size by Country (2026-2031)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 EUROPE
8.1 Europe AI Medical Imaging Software for Lung Diseases Market Size (2020-2031)
8.2 Europe AI Medical Imaging Software for Lung Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
8.3 Europe AI Medical Imaging Software for Lung Diseases Market Size by Country (2020-2025)
8.4 Europe AI Medical Imaging Software for Lung Diseases Market Size by Country (2026-2031)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size (2020-2031)
9.2 Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size by Country (2020-2025)
9.4 Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size by Country (2026-2031)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 SOUTH AMERICA
10.1 South America AI Medical Imaging Software for Lung Diseases Market Size (2020-2031)
10.2 South America AI Medical Imaging Software for Lung Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 South America AI Medical Imaging Software for Lung Diseases Market Size by Country (2020-2025)
10.4 South America AI Medical Imaging Software for Lung Diseases Market Size by Country (2026-2031)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa AI Medical Imaging Software for Lung Diseases Market Size (2020-2031)
11.2 Middle East & Africa AI Medical Imaging Software for Lung Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
11.3 Middle East & Africa AI Medical Imaging Software for Lung Diseases Market Size by Country (2020-2025)
11.4 Middle East & Africa AI Medical Imaging Software for Lung Diseases Market Size by Country (2026-2031)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 PLAYERS PROFILED
12.1 Riverain Technologies
12.1.1 Riverain Technologies Company Information
12.1.2 Riverain Technologies Business Overview
12.1.3 Riverain Technologies Revenue in AI Medical Imaging Software for Lung Diseases Business (2020-2025)
12.1.4 Riverain Technologies AI Medical Imaging Software for Lung Diseases Product Portfolio
12.1.5 Riverain Technologies Recent Developments
12.2 BioMind
12.2.1 BioMind Company Information
12.2.2 BioMind Business Overview
12.2.3 BioMind Revenue in AI Medical Imaging Software for Lung Diseases Business (2020-2025)
12.2.4 BioMind AI Medical Imaging Software for Lung Diseases Product Portfolio
12.2.5 BioMind Recent Developments
12.3 Fosun Aitrox
12.3.1 Fosun Aitrox Company Information
12.3.2 Fosun Aitrox Business Overview
12.3.3 Fosun Aitrox Revenue in AI Medical Imaging Software for Lung Diseases Business (2020-2025)
12.3.4 Fosun Aitrox AI Medical Imaging Software for Lung Diseases Product Portfolio
12.3.5 Fosun Aitrox Recent Developments
12.4 Huiying Medical
12.4.1 Huiying Medical Company Information
12.4.2 Huiying Medical Business Overview
12.4.3 Huiying Medical Revenue in AI Medical Imaging Software for Lung Diseases Business (2020-2025)
12.4.4 Huiying Medical AI Medical Imaging Software for Lung Diseases Product Portfolio
12.4.5 Huiying Medical Recent Developments
12.5 United-Imaging
12.5.1 United-Imaging Company Information
12.5.2 United-Imaging Business Overview
12.5.3 United-Imaging Revenue in AI Medical Imaging Software for Lung Diseases Business (2020-2025)
12.5.4 United-Imaging AI Medical Imaging Software for Lung Diseases Product Portfolio
12.5.5 United-Imaging Recent Developments
12.6 Deepwise
12.6.1 Deepwise Company Information
12.6.2 Deepwise Business Overview
12.6.3 Deepwise Revenue in AI Medical Imaging Software for Lung Diseases Business (2020-2025)
12.6.4 Deepwise AI Medical Imaging Software for Lung Diseases Product Portfolio
12.6.5 Deepwise Recent Developments
12.7 Shukun Technology
12.7.1 Shukun Technology Company Information
12.7.2 Shukun Technology Business Overview
12.7.3 Shukun Technology Revenue in AI Medical Imaging Software for Lung Diseases Business (2020-2025)
12.7.4 Shukun Technology AI Medical Imaging Software for Lung Diseases Product Portfolio
12.7.5 Shukun Technology Recent Developments
12.8 VoxelCloud
12.8.1 VoxelCloud Company Information
12.8.2 VoxelCloud Business Overview
12.8.3 VoxelCloud Revenue in AI Medical Imaging Software for Lung Diseases Business (2020-2025)
12.8.4 VoxelCloud AI Medical Imaging Software for Lung Diseases Product Portfolio
12.8.5 VoxelCloud Recent Developments
12.9 Infervision Medical
12.9.1 Infervision Medical Company Information
12.9.2 Infervision Medical Business Overview
12.9.3 Infervision Medical Revenue in AI Medical Imaging Software for Lung Diseases Business (2020-2025)
12.9.4 Infervision Medical AI Medical Imaging Software for Lung Diseases Product Portfolio
12.9.5 Infervision Medical Recent Developments
12.10 Siemens
12.10.1 Siemens Company Information
12.10.2 Siemens Business Overview
12.10.3 Siemens Revenue in AI Medical Imaging Software for Lung Diseases Business (2020-2025)
12.10.4 Siemens AI Medical Imaging Software for Lung Diseases Product Portfolio
12.10.5 Siemens Recent Developments
12.11 Yizhun Intelligent
12.11.1 Yizhun Intelligent Company Information
12.11.2 Yizhun Intelligent Business Overview
12.11.3 Yizhun Intelligent Revenue in AI Medical Imaging Software for Lung Diseases Business (2020-2025)
12.11.4 Yizhun Intelligent AI Medical Imaging Software for Lung Diseases Product Portfolio
12.11.5 Yizhun Intelligent Recent Developments
13 REPORT CONCLUSION
14 DISCLAIMER
